Overview

Biological Imaging Reagent Market is forecasted to value over USD 29.6 billion by 2028 end and register a CAGR of 8.5% from the forecast period 2021-2028.

FutureWise Market Research has instantiated a report on the Biological Imaging Reagent Market. The report provides an intricate analysis of the market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Biological Imaging Reagent Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Biological Imaging Reagent Market are:    

• Bayer AG
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• Guerbet  
• Lantheus Holdings, Inc.
• Bracco S.p.A.
• GE Healthcare
• Becton, Dickinson and Company (BD)
• Siemens Healthineers
• Luminex Corporation
(Note: The list of the major players will be updated with the latest market scenario and trends)

Biological Imaging Reagent Market Segmentation:

By Class
• Contrast Reagents
• Optical Reagents
• Nuclear Reagents

By Modality
• MRI
• Ultrasound
• X-ray & CT
• Nuclear
  o PET
  o SPECT
• Optical Imaging
• Others

By Application
• In Vitro
  o Proteomics
  o Genomics
  o Cell Biology
• In Vivo

By End User
• Diagnostic Laboratories
• Life Science Companies
• Imaging Centers
• Academic & Research Institutes
• Others

By Region
• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the market by class, by modality, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Global Biological Imaging Reagent Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Biological Imaging Reagent Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Biological Imaging Reagent Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Biological Imaging Reagent Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies

7. Global Biological Imaging Reagent Market, By Class Historical Analysis and Forecast 2021-2028 (USD Million)
        7.1. Contrast Reagents
        7.2. Optical Reagents
        7.3. Nuclear Reagents
8. Global Biological Imaging Reagent Market, By Modality Historical Analysis and Forecast 2021-2028 (USD Million)
         8.1 MRI
         8.2 Ultrasound
         8.3 X-ray & CT
         8.4 Nuclear
                8.4.1. PET
                8.4.2. SPECT
         8.5 Optical Imaging
         8.6 Others
9. Global Biological Imaging Reagent Market, By Application Historical Analysis and Forecast 2021-2028 (USD Million)
        9.1. In Vitro
               9.1.1. Proteomics
               9.1.2. Genomics
               9.1.3. Cell Biology
        9.2. In Vivo
10. Global Biological Imaging Reagent Market, By End User Historical Analysis and Forecast 2021-2028 (USD Million)
        10.1. Diagnostic Laboratories
        10.2. Life Science Companies
        10.3. Imaging Centers
        10.4. Academic & Research Institutes
        10.5. Others
11. North America Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2021-2028 
12. Latin America Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2021-2028  
13. Europe Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2021-2028
14. Asia Pacific Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2021–2028 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2021-2028 
16. Market Share Analysis and Competitive Landscape   
    16.1. Global Landscape - Key Players, Revenue and Presence
    16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    16.3. Global Emerging Companies
    16.4. North America - Market Share Analysis and Key Regional Players
    16.5. Europe - Market Share Analysis and Key Regional Players
    16.6. Asia Pacific - Market Share Analysis and Key Regional Players
    16.7. Global Key Player - Growth Matrix          
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    17.1 Bayer AG
            17.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.1.2. Product Portfolio
            17.1.3. SWOT Analysis
            17.1.4. Financial Overview
            17.1.5. Strategic Overview
    17.2 Thermo Fisher Scientific, Inc.
            17.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.2.2. Product Portfolio
            17.2.3. SWOT Analysis
            17.2.4. Financial Overview
            17.2.5. Strategic Overview
    17.3 PerkinElmer, Inc.
            17.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2. Product Portfolio
            17.3.3. SWOT Analysis
            17.3.4. Financial Overview
            17.3.5. Strategic Overview
    17.4 Guerbet
            17.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.4.2. Product Portfolio
            17.4.3. SWOT Analysis
            17.4.4. Financial Overview
            17.4.5. Strategic Overview
    17.5  Lantheus Holdings, Inc.
            17.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.5.2. Product Portfolio
            17.5.3. SWOT Analysis
            17.5.4. Financial Overview
            17.5.5. Strategic Overview
    17.6 Bracco S.p.A.
            17.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.6.2. Product Portfolio
            17.6.3. SWOT Analysis
            17.6.4. Financial Overview
            17.6.5. Strategic Overview
    17.7 GE Healthcare
            17.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.7.2. Product Portfolio
            17.7.3. SWOT Analysis
            17.7.4. Financial Overview
            17.7.5. Strategic Overview
    17.8  Becton, Dickinson and Company (BD)
            17.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.8.2. Product Portfolio
            17.8.3. SWOT Analysis
            17.8.4. Financial Overview
            17.8.5. Strategic Overview
    17.9  Siemens Healthineers
            17.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.9.2. Product Portfolio
            17.9.3. SWOT Analysis
            17.9.4. Financial Overview
            17.9.5. Strategic Overview
    17.10  Luminex Corporation
            17.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.10.2. Product Portfolio
            17.10.3. SWOT Analysis
            17.10.4. Financial Overview
            17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact
    18.1. Positive influence on the healthcare industry
    18.2. The financial disruption of the manufacturing sector
    18.3. Impact of COVID-19 on emerging companies
    18.4. Significant mandates in the healthcare regulations initiated by administrations
    18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Tables

Figures